Arbutus Biopharma Corporation

NASDAQ:ABUS

3.18 (USD) • At close December 24, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998
Operating Activities:
Net Income -72.849-69.456-76.247-63.745-153.723-57.1-84.4-384.164-61.121-38.837-14.06429.948-9.733-12.413-9.326-11.718-2.58318.081-8.059-28.05-34.076-26.794-14.015-9.203-8.173-8.754
Depreciation & Amortization 1.4041.4271.7531.9782.0282.1812.0271.0920.5890.5290.6130.870.9551.0381.9141.1150.4120.62.3971.26.8025.5853.8511.2571.3050.99
Deferred Income Tax 00-8.177-5.594-12.661-4.282-24.32-105.061-16.185-4.298-0.0183.8689.791-0.6430.10300.424000000000
Stock Based Compensation 9.3017.1826.4246.1616.7996.24115.11739.15922.0933.2830.9030.9870.6130.6510.25400.38000000000
Change In Working Capital -18.23329.2430.930.431-2.225-4.2753.147-0.467-14.63116.5192.298-2.4491.111-0.5291.5622.68-1.597-0.553-3.0921.636-1.962.836-0.2280.1060.020.055
Accounts Receivables -0.424-0.4530.413-0.1080.227-1.029-0.1290.7350.628-1.8870.889-0.192.388-2.265-0.4020-1.126000000000
Inventory 6.1820-1.911000.762-0.88-0.1620.32-1.1851.201-1.7680.148-0.1510.1670.032-0.215000000000
Accounts Payables -5.7585.2161.9111.666-2.41-1.2660.7360.026-2.4896.2530.13-0.197-2,179,372498,09600-0.045000000000
Other Working Capital -18.23324.480.517-1.127-0.042-2.7423.42-1.066-13.0913.3380.077-0.2952,179,370.576-498,094.1131.7972.648-0.21000000000
Other Non Cash Items -5.559-3.7527.7859.32888.776-10.66539.829391.55614.4710.3833.530.047-10.2590.6510.254-0.5610.244-20.751-5.81915.2312.270.2160.389-0.5140.0120
Operating Cash Flow -85.936-35.356-67.532-51.441-71.006-67.9-48.6-57.885-54.785-12.421-6.73933.271-7.521-11.247-5.239-8.484-2.72-2.623-14.573-9.983-26.964-18.157-10.004-8.354-6.837-7.709
Investing Activities:
Investments In Property Plant And Equipment -1.008-0.512-0.809-0.229-0.589-1.138-7.264-3.996-2.287-1.056-0.725-0.015-0.058-0.831-1.623-0.966-1.364-0.095-0.045-7.149-0.788-1.951-0.942-0.204-0.301-3.223
Acquisitions Net 00.4581.808-2.50.0110.0250.0030.0250.3240000002.070000000000
Purchases Of Investments -80.509-130.43-82.219-85.578-58.759-3.0140-95.1520-41.982000000000000-1.01-13.001-2.6940
Sales Maturities Of Investments 132.275670.3573.39887.675035.08609.645000005.4732.1420003.93717.811000010.262
Other Investing Activites 0.02-0.458-1.808-12.1828.927-2.96235.0640.0259.6450.08-725,1000.003-59,6750000.0010.0140.425-0.995-04.9020.097-00.0030.096
Investing Cash Flow 50.773-74.942-12.678-14.90928.338-4.127.8-99.1237.682-42.958-0.725-0.012-0.058-0.8313.853.245-1.363-0.0810.38-4.20817.0232.951-1.854-13.205-2.9927.136
Financing Activities:
Debt Repayment 00000-12.001012.0010000000-0.062-0.098-0.1-1.195-0.050.47-0.158-0.096-0.03900
Common Stock Issued 29.85220.324134.66586.29718.60167.64749.3220.637142.17756.47732.0383.8444.5990.0340.0088.18815.16000.63120.1340.25130.51313.1119.8890.049
Common Stock Repurchased 00000000000000000000000000
Dividends Paid 00-12.139-12.123-11.149-10.09100000000000000000000
Other Financing Activities 0.79511.4914.7112.57230.00577.73849.3220.6371.6934.1990.6780.7030.011000.0255.23-2.77500.24809.6965.146-000
Financing Cash Flow 30.64731.814137.23686.74637.45755.649.312.638143.8760.67632.7164.5684.4630.0350.0088.15120.292-2.875-1.1950.82920.6049.78835.56313.07219.8890.049
Other Information:
Effect Of Forex Changes On Cash 0.025-0.0220.0050.0560.068-12.41.004-2.175-1.827-3.56-0.0290.02-0.007-0.3571.437-0.8050000000-0-0
Net Change In Cash -4.491-78.50657.03120.452-5.143-17.430.9-143.36694.5923.4721.69237.797-3.097-12.05-1.7394.34915.404-5.578-15.389-13.36110.663-5.41823.705-8.48710.06-0.524
Cash At End Of Period 26.28530.776109.28252.25131.79936.954.323.413166.77972.18768.71747.0298.99512.34423.321.54321.134.86510.48124.99435.55620.50425.6342.04810.9070.798